Click for best price
Parenteral Drugs Market Size, Share 2022
Market Analysis and Insights: Global Parenteral Drugs Market
The global Parenteral Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Parenteral Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Parenteral Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Parenteral Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Parenteral Drugs market.
Global Parenteral Drugs Scope and Market Size
Parenteral Drugs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Parenteral Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
LVP Drug
SVP Drug
Segment by Application
Hospitals
Medical Centers
Others
By Company
Ostuka Pharmaceutical
Teva Pharmaceutical Industries
Kelun Pharma
Cook Pharmica
Patheon
BAG Healthcare
Beximco Pharma
Baxter Healthcare Corporation
B. Braun
Fresenius
Albert David
BML Parenteral Drugs
Pfizer (Hospira)
Pisa
Ozon Pharmaceuticals Ltd
Aspen Holdings
PSI Ltd
Wintac Limited
AXA Parenterals Ltd
Acebright
Southwest Pharmaceutical
Abbott
By Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Parenteral Drugs product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Parenteral Drugs, with price, sales, revenue, and global market share of Parenteral Drugs from 2019 to 2022.
Chapter 3, the Parenteral Drugs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Parenteral Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Parenteral Drugs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Parenteral Drugs.
Chapter 13, 14, and 15, to describe Parenteral Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Parenteral Drugs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global Parenteral Drugs Market Insights and Forecast to 2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
129 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Parenteral Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Parenteral Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 LVP Drug
1.2.3 SVP Drug
1.3 Market by Application
1.3.1 Global Parenteral Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Medical Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Parenteral Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Parenteral Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Parenteral Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Parenteral Drugs Sales by Region
2.4.1 Global Parenteral Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Parenteral Drugs by Region (2023-2028)
2.5 Global Parenteral Drugs Revenue by Region
2.5.1 Global Parenteral Drugs Revenue by Region (2017-2022)
2.5.2 Global Parenteral Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Parenteral Drugs Sales by Manufacturers
3.1.1 Global Top Parenteral Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Parenteral Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Parenteral Drugs in 2021
3.2 Global Parenteral Drugs Revenue by Manufacturers
3.2.1 Global Parenteral Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Parenteral Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Parenteral Drugs Revenue in 2021
3.3 Global Parenteral Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Parenteral Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Parenteral Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Parenteral Drugs Sales by Type
4.1.1 Global Parenteral Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Parenteral Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Parenteral Drugs Sales Market Share by Type (2017-2028)
4.2 Global Parenteral Drugs Revenue by Type
4.2.1 Global Parenteral Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Parenteral Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Parenteral Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Parenteral Drugs Price by Type
4.3.1 Global Parenteral Drugs Price by Type (2017-2022)
4.3.2 Global Parenteral Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Parenteral Drugs Sales by Application
5.1.1 Global Parenteral Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Parenteral Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Parenteral Drugs Sales Market Share by Application (2017-2028)
5.2 Global Parenteral Drugs Revenue by Application
5.2.1 Global Parenteral Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Parenteral Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Parenteral Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Parenteral Drugs Price by Application
5.3.1 Global Parenteral Drugs Price by Application (2017-2022)
5.3.2 Global Parenteral Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Parenteral Drugs Market Size by Type
6.1.1 North America Parenteral Drugs Sales by Type (2017-2028)
6.1.2 North America Parenteral Drugs Revenue by Type (2017-2028)
6.2 North America Parenteral Drugs Market Size by Application
6.2.1 North America Parenteral Drugs Sales by Application (2017-2028)
6.2.2 North America Parenteral Drugs Revenue by Application (2017-2028)
6.3 North America Parenteral Drugs Market Size by Country
6.3.1 North America Parenteral Drugs Sales by Country (2017-2028)
6.3.2 North America Parenteral Drugs Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
6.3.5 Mexico
7 Europe
7.1 Europe Parenteral Drugs Market Size by Type
7.1.1 Europe Parenteral Drugs Sales by Type (2017-2028)
7.1.2 Europe Parenteral Drugs Revenue by Type (2017-2028)
7.2 Europe Parenteral Drugs Market Size by Application
7.2.1 Europe Parenteral Drugs Sales by Application (2017-2028)
7.2.2 Europe Parenteral Drugs Revenue by Application (2017-2028)
7.3 Europe Parenteral Drugs Market Size by Country
7.3.1 Europe Parenteral Drugs Sales by Country (2017-2028)
7.3.2 Europe Parenteral Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Parenteral Drugs Market Size by Type
8.1.1 Asia Pacific Parenteral Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Parenteral Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Parenteral Drugs Market Size by Application
8.2.1 Asia Pacific Parenteral Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Parenteral Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Parenteral Drugs Market Size by Region
8.3.1 Asia Pacific Parenteral Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Parenteral Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Parenteral Drugs Market Size by Type
9.1.1 Latin America Parenteral Drugs Sales by Type (2017-2028)
9.1.2 Latin America Parenteral Drugs Revenue by Type (2017-2028)
9.2 Latin America Parenteral Drugs Market Size by Application
9.2.1 Latin America Parenteral Drugs Sales by Application (2017-2028)
9.2.2 Latin America Parenteral Drugs Revenue by Application (2017-2028)
9.3 Latin America Parenteral Drugs Market Size by Country
9.3.1 Latin America Parenteral Drugs Sales by Country (2017-2028)
9.3.2 Latin America Parenteral Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Parenteral Drugs Market Size by Type
10.1.1 Middle East and Africa Parenteral Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Parenteral Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Parenteral Drugs Market Size by Application
10.2.1 Middle East and Africa Parenteral Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Parenteral Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Parenteral Drugs Market Size by Country
10.3.1 Middle East and Africa Parenteral Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Parenteral Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Ostuka Pharmaceutical
11.1.1 Ostuka Pharmaceutical Corporation Information
11.1.2 Ostuka Pharmaceutical Overview
11.1.3 Ostuka Pharmaceutical Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Ostuka Pharmaceutical Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Ostuka Pharmaceutical Recent Developments
11.2 Teva Pharmaceutical Industries
11.2.1 Teva Pharmaceutical Industries Corporation Information
11.2.2 Teva Pharmaceutical Industries Overview
11.2.3 Teva Pharmaceutical Industries Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Teva Pharmaceutical Industries Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Teva Pharmaceutical Industries Recent Developments
11.3 Kelun Pharma
11.3.1 Kelun Pharma Corporation Information
11.3.2 Kelun Pharma Overview
11.3.3 Kelun Pharma Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Kelun Pharma Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Kelun Pharma Recent Developments
11.4 Cook Pharmica
11.4.1 Cook Pharmica Corporation Information
11.4.2 Cook Pharmica Overview
11.4.3 Cook Pharmica Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Cook Pharmica Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Cook Pharmica Recent Developments
11.5 Patheon
11.5.1 Patheon Corporation Information
11.5.2 Patheon Overview
11.5.3 Patheon Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Patheon Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Patheon Recent Developments
11.6 BAG Healthcare
11.6.1 BAG Healthcare Corporation Information
11.6.2 BAG Healthcare Overview
11.6.3 BAG Healthcare Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 BAG Healthcare Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 BAG Healthcare Recent Developments
11.7 Beximco Pharma
11.7.1 Beximco Pharma Corporation Information
11.7.2 Beximco Pharma Overview
11.7.3 Beximco Pharma Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Beximco Pharma Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Beximco Pharma Recent Developments
11.8 Baxter Healthcare Corporation
11.8.1 Baxter Healthcare Corporation Corporation Information
11.8.2 Baxter Healthcare Corporation Overview
11.8.3 Baxter Healthcare Corporation Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Baxter Healthcare Corporation Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Baxter Healthcare Corporation Recent Developments
11.9 B. Braun
11.9.1 B. Braun Corporation Information
11.9.2 B. Braun Overview
11.9.3 B. Braun Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 B. Braun Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 B. Braun Recent Developments
11.10 Fresenius
11.10.1 Fresenius Corporation Information
11.10.2 Fresenius Overview
11.10.3 Fresenius Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Fresenius Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Fresenius Recent Developments
11.11 Albert David
11.11.1 Albert David Corporation Information
11.11.2 Albert David Overview
11.11.3 Albert David Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Albert David Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Albert David Recent Developments
11.12 BML Parenteral Drugs
11.12.1 BML Parenteral Drugs Corporation Information
11.12.2 BML Parenteral Drugs Overview
11.12.3 BML Parenteral Drugs Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 BML Parenteral Drugs Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 BML Parenteral Drugs Recent Developments
11.13 Pfizer (Hospira)
11.13.1 Pfizer (Hospira) Corporation Information
11.13.2 Pfizer (Hospira) Overview
11.13.3 Pfizer (Hospira) Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Pfizer (Hospira) Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Pfizer (Hospira) Recent Developments
11.14 Pisa
11.14.1 Pisa Corporation Information
11.14.2 Pisa Overview
11.14.3 Pisa Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Pisa Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Pisa Recent Developments
11.15 Ozon Pharmaceuticals Ltd
11.15.1 Ozon Pharmaceuticals Ltd Corporation Information
11.15.2 Ozon Pharmaceuticals Ltd Overview
11.15.3 Ozon Pharmaceuticals Ltd Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Ozon Pharmaceuticals Ltd Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Ozon Pharmaceuticals Ltd Recent Developments
11.16 Aspen Holdings
11.16.1 Aspen Holdings Corporation Information
11.16.2 Aspen Holdings Overview
11.16.3 Aspen Holdings Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Aspen Holdings Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Aspen Holdings Recent Developments
11.17 PSI Ltd
11.17.1 PSI Ltd Corporation Information
11.17.2 PSI Ltd Overview
11.17.3 PSI Ltd Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 PSI Ltd Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 PSI Ltd Recent Developments
11.18 Wintac Limited
11.18.1 Wintac Limited Corporation Information
11.18.2 Wintac Limited Overview
11.18.3 Wintac Limited Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Wintac Limited Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Wintac Limited Recent Developments
11.19 AXA Parenterals Ltd
11.19.1 AXA Parenterals Ltd Corporation Information
11.19.2 AXA Parenterals Ltd Overview
11.19.3 AXA Parenterals Ltd Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 AXA Parenterals Ltd Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 AXA Parenterals Ltd Recent Developments
11.20 Acebright
11.20.1 Acebright Corporation Information
11.20.2 Acebright Overview
11.20.3 Acebright Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Acebright Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Acebright Recent Developments
11.21 Southwest Pharmaceutical
11.21.1 Southwest Pharmaceutical Corporation Information
11.21.2 Southwest Pharmaceutical Overview
11.21.3 Southwest Pharmaceutical Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 Southwest Pharmaceutical Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Southwest Pharmaceutical Recent Developments
11.22 Abbott
11.22.1 Abbott Corporation Information
11.22.2 Abbott Overview
11.22.3 Abbott Parenteral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.22.4 Abbott Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Abbott Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Parenteral Drugs Industry Chain Analysis
12.2 Parenteral Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Parenteral Drugs Production Mode & Process
12.4 Parenteral Drugs Sales and Marketing
12.4.1 Parenteral Drugs Sales Channels
12.4.2 Parenteral Drugs Distributors
12.5 Parenteral Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Parenteral Drugs Industry Trends
13.2 Parenteral Drugs Market Drivers
13.3 Parenteral Drugs Market Challenges
13.4 Parenteral Drugs Market Restraints
14 Key Findings in The Global Parenteral Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Global Parenteral Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of LVP Drug
Table 3. Major Manufacturers of SVP Drug
Table 4. Global Parenteral Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Parenteral Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Parenteral Drugs Sales by Region (2017-2022) & (K Units)
Table 7. Global Parenteral Drugs Sales Market Share by Region (2017-2022)
Table 8. Global Parenteral Drugs Sales by Region (2023-2028) & (K Units)
Table 9. Global Parenteral Drugs Sales Market Share by Region (2023-2028)
Table 10. Global Parenteral Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Parenteral Drugs Revenue Market Share by Region (2017-2022)
Table 12. Global Parenteral Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Parenteral Drugs Revenue Market Share by Region (2023-2028)
Table 14. Global Parenteral Drugs Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Parenteral Drugs Sales Share by Manufacturers (2017-2022)
Table 16. Global Parenteral Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Parenteral Drugs Revenue Share by Manufacturers (2017-2022)
Table 18. Parenteral Drugs Price by Manufacturers (2017-2022) &(USD/Unit)
Table 19. Global Parenteral Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Parenteral Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parenteral Drugs as of 2021)
Table 21. Parenteral Drugs Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Parenteral Drugs Product Offered
Table 23. Date of Manufacturers Enter into Parenteral Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Parenteral Drugs Sales by Type (2017-2022) & (K Units)
Table 26. Global Parenteral Drugs Sales by Type (2023-2028) & (K Units)
Table 27. Global Parenteral Drugs Sales Share by Type (2017-2022)
Table 28. Global Parenteral Drugs Sales Share by Type (2023-2028)
Table 29. Global Parenteral Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Parenteral Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Parenteral Drugs Revenue Share by Type (2017-2022)
Table 32. Global Parenteral Drugs Revenue Share by Type (2023-2028)
Table 33. Parenteral Drugs Price by Type (2017-2022) & (USD/Unit)
Table 34. Global Parenteral Drugs Price Forecast by Type (2023-2028) & (USD/Unit)
Table 35. Global Parenteral Drugs Sales by Application (2017-2022) & (K Units)
Table 36. Global Parenteral Drugs Sales by Application (2023-2028) & (K Units)
Table 37. Global Parenteral Drugs Sales Share by Application (2017-2022)
Table 38. Global Parenteral Drugs Sales Share by Application (2023-2028)
Table 39. Global Parenteral Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Parenteral Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Parenteral Drugs Revenue Share by Application (2017-2022)
Table 42. Global Parenteral Drugs Revenue Share by Application (2023-2028)
Table 43. Parenteral Drugs Price by Application (2017-2022) & (USD/Unit)
Table 44. Global Parenteral Drugs Price Forecast by Application (2023-2028) & (USD/Unit)
Table 45. North America Parenteral Drugs Sales by Type (2017-2022) & (K Units)
Table 46. North America Parenteral Drugs Sales by Type (2023-2028) & (K Units)
Table 47. North America Parenteral Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Parenteral Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Parenteral Drugs Sales by Application (2017-2022) & (K Units)
Table 50. North America Parenteral Drugs Sales by Application (2023-2028) & (K Units)
Table 51. North America Parenteral Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Parenteral Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Parenteral Drugs Sales by Country (2017-2022) & (K Units)
Table 54. North America Parenteral Drugs Sales by Country (2023-2028) & (K Units)
Table 55. North America Parenteral Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Parenteral Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Parenteral Drugs Sales by Type (2017-2022) & (K Units)
Table 58. Europe Parenteral Drugs Sales by Type (2023-2028) & (K Units)
Table 59. Europe Parenteral Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Parenteral Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Parenteral Drugs Sales by Application (2017-2022) & (K Units)
Table 62. Europe Parenteral Drugs Sales by Application (2023-2028) & (K Units)
Table 63. Europe Parenteral Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Parenteral Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Parenteral Drugs Sales by Country (2017-2022) & (K Units)
Table 66. Europe Parenteral Drugs Sales by Country (2023-2028) & (K Units)
Table 67. Europe Parenteral Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Parenteral Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Parenteral Drugs Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Parenteral Drugs Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Parenteral Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Parenteral Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Parenteral Drugs Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Parenteral Drugs Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Parenteral Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Parenteral Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Parenteral Drugs Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Parenteral Drugs Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Parenteral Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Parenteral Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Parenteral Drugs Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Parenteral Drugs Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Parenteral Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Parenteral Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Parenteral Drugs Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Parenteral Drugs Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Parenteral Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Parenteral Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Parenteral Drugs Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Parenteral Drugs Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Parenteral Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Parenteral Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Parenteral Drugs Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Parenteral Drugs Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Parenteral Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Parenteral Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Parenteral Drugs Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Parenteral Drugs Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Parenteral Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Parenteral Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Parenteral Drugs Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Parenteral Drugs Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Parenteral Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Parenteral Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 105. Ostuka Pharmaceutical Corporation Information
Table 106. Ostuka Pharmaceutical Description and Major Businesses
Table 107. Ostuka Pharmaceutical Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 108. Ostuka Pharmaceutical Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Ostuka Pharmaceutical Recent Developments
Table 110. Teva Pharmaceutical Industries Corporation Information
Table 111. Teva Pharmaceutical Industries Description and Major Businesses
Table 112. Teva Pharmaceutical Industries Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 113. Teva Pharmaceutical Industries Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Teva Pharmaceutical Industries Recent Developments
Table 115. Kelun Pharma Corporation Information
Table 116. Kelun Pharma Description and Major Businesses
Table 117. Kelun Pharma Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 118. Kelun Pharma Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Kelun Pharma Recent Developments
Table 120. Cook Pharmica Corporation Information
Table 121. Cook Pharmica Description and Major Businesses
Table 122. Cook Pharmica Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 123. Cook Pharmica Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Cook Pharmica Recent Developments
Table 125. Patheon Corporation Information
Table 126. Patheon Description and Major Businesses
Table 127. Patheon Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 128. Patheon Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Patheon Recent Developments
Table 130. BAG Healthcare Corporation Information
Table 131. BAG Healthcare Description and Major Businesses
Table 132. BAG Healthcare Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 133. BAG Healthcare Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. BAG Healthcare Recent Developments
Table 135. Beximco Pharma Corporation Information
Table 136. Beximco Pharma Description and Major Businesses
Table 137. Beximco Pharma Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 138. Beximco Pharma Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Beximco Pharma Recent Developments
Table 140. Baxter Healthcare Corporation Corporation Information
Table 141. Baxter Healthcare Corporation Description and Major Businesses
Table 142. Baxter Healthcare Corporation Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 143. Baxter Healthcare Corporation Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Baxter Healthcare Corporation Recent Developments
Table 145. B. Braun Corporation Information
Table 146. B. Braun Description and Major Businesses
Table 147. B. Braun Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 148. B. Braun Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. B. Braun Recent Developments
Table 150. Fresenius Corporation Information
Table 151. Fresenius Description and Major Businesses
Table 152. Fresenius Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 153. Fresenius Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Fresenius Recent Developments
Table 155. Albert David Corporation Information
Table 156. Albert David Description and Major Businesses
Table 157. Albert David Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 158. Albert David Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Albert David Recent Developments
Table 160. BML Parenteral Drugs Corporation Information
Table 161. BML Parenteral Drugs Description and Major Businesses
Table 162. BML Parenteral Drugs Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 163. BML Parenteral Drugs Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. BML Parenteral Drugs Recent Developments
Table 165. Pfizer (Hospira) Corporation Information
Table 166. Pfizer (Hospira) Description and Major Businesses
Table 167. Pfizer (Hospira) Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 168. Pfizer (Hospira) Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Pfizer (Hospira) Recent Developments
Table 170. Pisa Corporation Information
Table 171. Pisa Description and Major Businesses
Table 172. Pisa Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 173. Pisa Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. Pisa Recent Developments
Table 175. Ozon Pharmaceuticals Ltd Corporation Information
Table 176. Ozon Pharmaceuticals Ltd Description and Major Businesses
Table 177. Ozon Pharmaceuticals Ltd Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 178. Ozon Pharmaceuticals Ltd Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. Ozon Pharmaceuticals Ltd Recent Developments
Table 180. Aspen Holdings Corporation Information
Table 181. Aspen Holdings Description and Major Businesses
Table 182. Aspen Holdings Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 183. Aspen Holdings Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 184. Aspen Holdings Recent Developments
Table 185. PSI Ltd Corporation Information
Table 186. PSI Ltd Description and Major Businesses
Table 187. PSI Ltd Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 188. PSI Ltd Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 189. PSI Ltd Recent Developments
Table 190. Wintac Limited Corporation Information
Table 191. Wintac Limited Description and Major Businesses
Table 192. Wintac Limited Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 193. Wintac Limited Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 194. Wintac Limited Recent Developments
Table 195. AXA Parenterals Ltd Corporation Information
Table 196. AXA Parenterals Ltd Description and Major Businesses
Table 197. AXA Parenterals Ltd Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 198. AXA Parenterals Ltd Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 199. AXA Parenterals Ltd Recent Developments
Table 200. Acebright Corporation Information
Table 201. Acebright Description and Major Businesses
Table 202. Acebright Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 203. Acebright Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 204. Acebright Recent Developments
Table 205. Southwest Pharmaceutical Corporation Information
Table 206. Southwest Pharmaceutical Description and Major Businesses
Table 207. Southwest Pharmaceutical Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 208. Southwest Pharmaceutical Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 209. Southwest Pharmaceutical Recent Developments
Table 210. Abbott Corporation Information
Table 211. Abbott Description and Major Businesses
Table 212. Abbott Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 213. Abbott Parenteral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 214. Abbott Recent Developments
Table 215. Key Raw Materials Lists
Table 216. Raw Materials Key Suppliers Lists
Table 217. Parenteral Drugs Distributors List
Table 218. Parenteral Drugs Customers List
Table 219. Parenteral Drugs Market Trends
Table 220. Parenteral Drugs Market Drivers
Table 221. Parenteral Drugs Market Challenges
Table 222. Parenteral Drugs Market Restraints
Table 223. Research Programs/Design for This Report
Table 224. Key Data Information from Secondary Sources
Table 225. Key Data Information from Primary Sources
List of Figures
Figure 1. Parenteral Drugs Product Picture
Figure 3. Global Parenteral Drugs Market Share by Type in 2021 & 2028
Figure 3. LVP Drug Product Picture
Figure 4. SVP Drug Product Picture
Figure 5. Global Parenteral Drugs Market Share by Application in 2021 & 2028
Figure 6. Hospitals
Figure 7. Medical Centers
Figure 8. Others
Figure 9. Parenteral Drugs Report Years Considered
Figure 10. Global Parenteral Drugs Sales 2017-2028 (K Units)
Figure 11. Global Parenteral Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Parenteral Drugs Revenue 2017-2028 (US$ Million)
Figure 13. Global Parenteral Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Parenteral Drugs Sales Market Share by Region (2017-2022)
Figure 15. Global Parenteral Drugs Sales Market Share by Region (2023-2028)
Figure 16. North America Parenteral Drugs Sales YoY (2017-2028) & (K Units)
Figure 17. North America Parenteral Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Parenteral Drugs Sales YoY (2017-2028) & (K Units)
Figure 19. Europe Parenteral Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Parenteral Drugs Sales YoY (2017-2028) & (K Units)
Figure 21. Asia-Pacific Parenteral Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Parenteral Drugs Sales YoY (2017-2028) & (K Units)
Figure 23. Latin America Parenteral Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Parenteral Drugs Sales YoY (2017-2028) & (K Units)
Figure 25. Middle East & Africa Parenteral Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Parenteral Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Parenteral Drugs in the World: Market Share by Parenteral Drugs Revenue in 2021
Figure 28. Global Parenteral Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Parenteral Drugs Sales Market Share by Type (2017-2028)
Figure 30. Global Parenteral Drugs Revenue Market Share by Type (2017-2028)
Figure 31. Global Parenteral Drugs Sales Market Share by Application (2017-2028)
Figure 32. Global Parenteral Drugs Revenue Market Share by Application (2017-2028)
Figure 33. North America Parenteral Drugs Sales Market Share by Type (2017-2028)
Figure 34. North America Parenteral Drugs Revenue Market Share by Type (2017-2028)
Figure 35. North America Parenteral Drugs Sales Market Share by Application (2017-2028)
Figure 36. North America Parenteral Drugs Revenue Market Share by Application (2017-2028)
Figure 37. North America Parenteral Drugs Sales Share by Country (2017-2028)
Figure 38. North America Parenteral Drugs Revenue Share by Country (2017-2028)
Figure 39. United States Parenteral Drugs Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Parenteral Drugs Revenue (2017-2028) & (US$ Million)
Figure 41. Mexico Parenteral Drugs Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Parenteral Drugs Sales Market Share by Type (2017-2028)
Figure 43. Europe Parenteral Drugs Revenue Market Share by Type (2017-2028)
Figure 44. Europe Parenteral Drugs Sales Market Share by Application (2017-2028)
Figure 45. Europe Parenteral Drugs Revenue Market Share by Application (2017-2028)
Figure 46. Europe Parenteral Drugs Sales Share by Country (2017-2028)
Figure 47. Europe Parenteral Drugs Revenue Share by Country (2017-2028)
Figure 48. Germany Parenteral Drugs Revenue (2017-2028) & (US$ Million)
Figure 49. France Parenteral Drugs Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Parenteral Drugs Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Parenteral Drugs Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Parenteral Drugs Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Parenteral Drugs Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Parenteral Drugs Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Parenteral Drugs Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Parenteral Drugs Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Parenteral Drugs Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Parenteral Drugs Revenue Share by Region (2017-2028)
Figure 59. China Parenteral Drugs Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Parenteral Drugs Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Parenteral Drugs Revenue (2017-2028) & (US$ Million)
Figure 62. India Parenteral Drugs Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Parenteral Drugs Revenue (2017-2028) & (US$ Million)
Figure 64. Taiwan Parenteral Drugs Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Parenteral Drugs Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Parenteral Drugs Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Parenteral Drugs Revenue (2017-2028) & (US$ Million)
Figure 68. Philippines Parenteral Drugs Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Parenteral Drugs Sales Market Share by Type (2017-2028)
Figure 70. Latin America Parenteral Drugs Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Parenteral Drugs Sales Market Share by Application (2017-2028)
Figure 72. Latin America Parenteral Drugs Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Parenteral Drugs Sales Share by Country (2017-2028)
Figure 74. Latin America Parenteral Drugs Revenue Share by Country (2017-2028)
Figure 75. Mexico Parenteral Drugs Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Parenteral Drugs Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Parenteral Drugs Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Parenteral Drugs Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Parenteral Drugs Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Parenteral Drugs Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Parenteral Drugs Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Parenteral Drugs Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Parenteral Drugs Revenue Share by Country (2017-2028)
Figure 84. Turkey Parenteral Drugs Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Parenteral Drugs Revenue (2017-2028) & (US$ Million)
Figure 86. U.A.E Parenteral Drugs Revenue (2017-2028) & (US$ Million)
Figure 87. Parenteral Drugs Value Chain
Figure 88. Parenteral Drugs Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
